VIRAMUNE cpr 200 mg 14 pce
7680543930175
CH-54393
J05AG01
08.03.0.
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 5439301
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- nevirapinum 200 mg, cellulosum microcristallinum, lactosum monohydricum 318 mg, povidonum K 25, carboxymethylamylum natricum A corresp. natrium 714 µg, silica colloidalis anhydrica, magnesii stearas pro compresso.
Articles (1)
Viramune, Tabletten
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nevirapinum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
318.0 MG | Substance | HBESI |
|
povidonum K 25
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
natrium
|
714.0 UG | Substance | HBESI |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Boehringer Ingelheim (Schweiz) GmbH
4057 Basel
Authorization information
- Swissmedic authorization number
- 54393
- Drug name
- Viramune, Tabletten
- Galenic form
- TAB
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/12/1997
- Authorization expiration date
- 31/08/2026
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VIRAMUNE cpr 200 mg 14 pce
- Description (DE)
- VIRAMUNE Tabl 200 mg 14 Stk
- Market launch
- 23/12/1997
- Market withdrawal
- 31/08/2026
- Narcotic (BTM)
- No